Suubi+Adherence4Youth: Helping Ugandan teens stick with HIV treatment
Official title: Suubi+Adherence4Youth: Optimizing the Suubi Intervention for Adherence to HIV Treatment for Youth Living with HIV in Uganda
Funded at New York University · NIH-11580973 · Data updated 2026-11-12
A study in Uganda will test which parts of a proven support program help adolescents with HIV follow their treatment and stay healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 1, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $14,580 |
| NIH project number | 3R01MH131507-05S2 |
| Project ID | NIH-11580973 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adolescents living with HIV in Uganda who can participate in the Suubi components (financial literacy, savings and income activities, adherence/stigma sessions, and mentor engagement).
✕Less likely to help
Some youths may not experience a strong benefit if certain components are less effective for them or if there are barriers to participation.
What this research studies
This project builds on Suubi, a known support program, and uses a factorial design to see which components most improve ART adherence and viral suppression among adolescents living with HIV in Uganda. It will involve social and economic supports, stigma reduction, and role-model engagement to address real-world barriers these youths face. By systematically testing each component and their combinations, the study aims to identify an efficient, effective suite of interventions that can be scaled if successful.
Why it matters
Potential benefit: If successful, the program could improve ART adherence and viral suppression among Ugandan adolescents with HIV, leading to better health and fewer dropouts from care.
How similar studies have gone: Previous Suubi studies showed positive effects on adherence and health outcomes, but this project tests which parts are essential for best results.
Where this research is happening
-
New York University
New York, United States Active
Researchers
- Principal investigator: Ssewamala, Fred M — New York University
- Study coordinator: Ssewamala, Fred M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.